Know Cancer

or
forgot password
  • cancer clinical trials in seattle, WA

  • Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Puget Sound Health Care System, Seattle
    Seattle, Washington 98108
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Seattle Children's Hospital
    Seattle, Washington 98105
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Fred Hutchinson Cancer Research Center

    Trial Locations
    Fred Hutchinson Cancer Research Center
    CCOP - Virginia Mason Research Center
    Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
    University Cancer Center at University of Washington Medical Center
    Harborview Medical Center
    Group Health Central Hospital
    Minor and James Medical, PLLC
    Polyclinic First Hill
    Pacific Medical Center
    Metastatic Cancer, Prostate Cancer
    A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
    University of Washington Medical Center
    Seattle, Washington 98195-6043
    Melanoma
    Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations
    Group Health Cooperative
    Seattle, Washington 98112
    Unspecified Adult Solid Tumor, Protocol Specific
    Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Seattle, Washington 98109
    Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
    University of Washington
    Seattle, Washington 98195
    Breast Cancer
    Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

    Trial Locations
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    VA Puget Sound Health Care System
    Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Veterans Administration Center-Seattle

    Trial Locations
    Veterans Administration Center-Seattle
    Minor and James Medical PLLC
    The Polyclinic
    Swedish Medical Center-First Hill
    Group Health Cooperative of Puget Sound Oncology Consortium
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Seattle, Washington 98109
    HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Stage IV Breast Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor
    S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
    Fred Hutchinson Cancer Research Center

    Trial Locations
    Fred Hutchinson Cancer Research Center
    Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
    University Cancer Center at University of Washington Medical Center
    Harborview Medical Center
    Group Health Central Hospital
    Minor and James Medical, PLLC
    Polyclinic First Hill
    Lymphoma
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    University Cancer Center at University of Washington Medical Center

    Trial Locations
    University Cancer Center at University of Washington Medical Center
    Harborview Medical Center
    Group Health Central Hospital
    Minor and James Medical, PLLC
    Polyclinic First Hill
    Bladder Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Virginia Mason Medical Center

    Trial Locations
    Virginia Mason Medical Center
    Virginia Mason CCOP
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    PhII ICb With/Without Erbitux in MBC Pts
    Puget Sound Cancer Center-Seattle
    Seattle, Washington 98133
    Metastatic Breast Cancer
    N2001-02: I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
    Children's Hospital and Regional Medical Center - Seattle
    Seattle, Washington 98105
    Neuroblastoma
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    University of Washington Medical Center
    Seattle, Washington 98195-6043
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Washington Medical Center

    Trial Locations
    University of Washington Medical Center
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Virginia Mason CCOP
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    University Cancer Center at University of Washington Medical Center

    Trial Locations
    University Cancer Center at University of Washington Medical Center
    Group Health Central Hospital
    Minor and James Medical, PLLC
    Colorectal Cancer
    Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
    University of Washington Medical Center
    Seattle, Washington 98195-6043
    Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Waldenström Macroglobulinemia
    Familial Barrett's Esophagus
    Fred Hutchinson Cancer Research Center, UWMC
    Seattle, Washington 98109
    Barrett's Esophagus, Esophageal Neoplasm
    High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
    Fred Hutchinson Cancer Research Center
    Seattle, Washington 98109
    Multiple Sclerosis
    Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
    GSK Investigational Site
    Seattle, Washington 98133
    Prophylaxis for HPV Infections and Associated Cervical Neoplasia
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Seattle, Washington 98133
    Glioblastoma
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    Children's Hospital and Regional Medical Center - Seattle
    Seattle, Washington 98105
    Neuroblastoma
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    University of Washington
    Seattle, Washington 98195
    Melanoma
    Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
    University of Washington

    Trial Locations
    University of Washington
    Veterans' Administration Puget Sound Health Care System (VAPSHCS)
    Cancer, Prostate Neoplasms